Iran's Cov-Pars vaccine enjoys 96-years of Razi institute experience
Feb 09, 2021 08:23 UTC
The head of Razi Vaccine and Serum Research Institute says the Razi Cov-Pars vaccine will be an excellent option as it is the first injectable-inhaled COVID-19 vaccine of recombinant protein.
MG
